Physician profile
Wanda M Boote
NPI 1063517050
$1,900.57
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $24.10 · 2023: $1,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,292 · Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,292.11 |
| Food and Beverage | $465.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,720.74 | 2023 | |
| Dusa Pharmaceuticals, INC. | $70.42 | 2019 | |
| Dermavant Sciences, INC. | $36.80 | 2023 | Vtama |
| Merz North America, INC. | $24.56 | 2019 | |
| Sun Pharmaceutical Industries INC. | $24.10 | 2020 | |
| Smith+Nephew, INC. | $23.95 | 2019 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wanda Boote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.